Yves P. AUBERSON (Novartis, Switzerland)
Maria Laura BOLOGNESI (University of Bologna, Italy)
Karin BRINER (Novartis, USA)
Herbert WALDMANN (Max Planck Institute of Molecular Physiology, Germany)
Tony WOOD (GlaxoSmithKline, United Kingdom)
The Advisory Board is an EFMC consulting body for the executive committee assisting in assessing the Federation's strategic goals. The tasks of the AB consists of:
The AB is composed of eminent scientists in the life sciences and medicinal chemistry and is chaired by the past president. The EFMC is thankful to all of them for their dedication and valuable contribution.
To see the previous composition of the Advisory Board, please click here